Elevai Labs Inc.
ELAB
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.4M
Close$
$0.50
82.6% downside
Current Fair Value
82.6% downsideOvervalued by 82.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.40 Million |
|---|---|
| Enterprise Value | $-2,825,498.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3787.4 |
| Beta | -0.27 |
| Outstanding Shares | 487,650 |
Return
| Return on Equity | 13.47% |
|---|---|
| Return on Assets | 6.17% |
| Return on Invested Capital | -63.93% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.57 |
| Price to Book Ratio | 0.08 |
| Enterprise Value to Revenue | -1.1 |
| Enterprise Value to EBIT | 0.21 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | -4.93 |
| Debt to Equity | 0.83 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.47%▲ 4.14% |
|---|---|
| Total Invested | $322,465▼ 16.96% |
| Investors Holding | 12▲ 6.00% |
ESG Score
No data